Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study

被引：104

作者：

Braeckman, Tessa ^{[1
]}

Van Herck, Koen ^{[11
]}

Meyer, Nadia ^{[2
]}

Pircon, Jean-Yves ^{[2
]}

Soriano-Gabarro, Montse ^{[3
]}

Heylen, Elisabeth ^{[4
]}

Zeller, Mark ^{[4
]}

Azou, Myriam ^{[5
]}

Capiau, Heidi ^{[6
]}

De Koster, Jan ^{[7
]}

Maernoudt, Anne-Sophie ^{[8
]}

Raes, Marc ^{[9
]}

Verdonck, Lutgard ^{[10
]}

Verghote, Marc ^{[11
]}

Vergison, Anne ^{[12
]}

Matthijnssens, Jelle ^{[4
]}

Van Ranst, Marc ^{[4
]}

Van Damme, Pierre ^{[1
]}

机构：

[1] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, B-2020 Antwerp, Belgium

[2] GlaxoSmithKline Biol, Wavre, Belgium

[3] Bayer Healthcare Pharmaceut, Berlin, Germany

[4] Katholieke Univ Leuven, Louvain, Belgium

[5] AZ Damiaan, Dept Paediat, Oostende, Belgium

[6] AZ St Lucas, Dept Paediat, Ghent, Belgium

[7] ZOL, Dept Paediat, Genk, Belgium

[8] Clin St Pierre, Dept Paediat, Ottignies, Belgium

[9] Jessa Hosp, Dept Paediat, Hasselt, Belgium

[10] AZ Alma, Dept Paediat, Eeklo, Belgium

[11] CHR Namur, Dept Paediat, Namur, Belgium

[12] Univ Hosp Children, Infect Dis Unit, Brussels, Belgium

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2012年 / 345卷

关键词：

DIARRHEA-ASSOCIATED HOSPITALIZATIONS; 1ST; 2; YEARS; DOUBLE-BLIND; DISEASE; EFFICACY; BURDEN; REDUCTION; INFANTS; SAFETY; VACCINES;

D O I：

10.1136/bmj.e4752

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective To evaluate the effectiveness of rotavirus vaccination among young children in Belgium. Design Prospective case-control study. Setting Random sample of 39 Belgian hospitals, February 2008 to June 2010. Participants 215 children admitted to hospital with rotavirus gastroenteritis confirmed by polymerase chain reaction and 276 age and hospital matched controls. All children were of an eligible age to have received rotavirus vaccination (that is, born after 1 October 2006 and aged >= 14 weeks). Main outcome measure Vaccination status of children admitted to hospital with rotavirus gastroenteritis and matched controls. Results 99 children (48%) admitted with rotavirus gastroenteritis and 244 (91%) controls had received at least one dose of any rotavirus vaccine (P<0.001). The monovalent rotavirus vaccine accounted for 92% (n=594) of all rotavirus vaccine doses. With hospital admission as the outcome, the unadjusted effectiveness of two doses of the monovalent rotavirus vaccine was 90% (95% confidence interval 81% to 95%) overall, 91% (75% to 97%) in children aged 3-11 months, and 90% (76% to 96%) in those aged >= 12 months. The G2P[4] genotype accounted for 52% of cases confirmed by polymerase chain reaction with eligible matched controls. Vaccine effectiveness was 85% (64% to 94%) against G2P[4] and 95% (78% to 99%) against G1P[8]. In 25% of cases confirmed by polymerase chain reaction with eligible matched controls, there was reported co-infection with adenovirus, astrovirus and/or norovirus. Vaccine effectiveness against co-infected cases was 86% (52% to 96%). Effectiveness of at least one dose of any rotavirus vaccine (intention to vaccinate analysis) was 91% (82% to 95%). Conclusions Rotavirus vaccination is effective for the prevention of admission to hospital for rotavirus gastroenteritis among young children in Belgium, despite the high prevalence of G2P[4] and viral co-infection.

引用

页数：13

共 51 条

[1]

[Anonymous], 2009, Wkly Epidemiol Rec, V84, P533

[2]

[Anonymous], 2008, Generic Protocol for Monitoring Impact of Rotavirus Vaccination on Gastroenteritis Disease Burdenand Viral Strains

[3]

Bilcke J, 2007, 54C KCE

[4] The health and economic burden of rotavirus disease in Belgium [J].

Bilcke, Joke ;

Van Damme, Pierre ;

De Smet, Frank ;

Hanquet, Germaine ;

Van Ranst, Marc ;

Beutels, Philippe .

EUROPEAN JOURNAL OF PEDIATRICS, 2008, 167 (12) :1409-1419

[5] Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver(s) and "No Medical Care" Disease Impact in Belgium [J].

Bilcke, Joke ;

Van Damme, Pierre ;

Beutels, Philippe .

MEDICAL DECISION MAKING, 2009, 29 (01) :33-50

[6] Effectiveness of Pentavalent Rotavirus Vaccine in a Large Urban Population in the United States [J].

Boom, Julie A. ;

Tate, Jacqueline E. ;

Sahni, Leila C. ;

Rench, Marcia A. ;

Hull, Jennifer J. ;

Gentsch, Jon R. ;

Patel, Manish M. ;

Baker, Carol J. ;

Parashar, Umesh D. .

PEDIATRICS, 2010, 125 (02) :E199-E207

[7]

Boonen M., 2009, Vlaams Infectieziektebulletin, V68, P9

[8] Rotavirus Vaccines in Belgium Policy and Impact [J].

Braeckman, Tessa ;

Van Herck, Koen ;

Raes, Marc ;

Vergison, Anne ;

Sabbe, Martine ;

Van Damme, Pierre .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (01) :S21-S24

[9] Reduction in Rotavirus-associated Acute Gastroenteritis Following Introduction of Rotavirus Vaccine Into Australia's National Childhood Vaccine Schedule [J].

Buttery, Jim P. ;

Lambert, Stephen B. ;

Grimwood, Keith ;

Nissen, Michael D. ;

Field, Emma J. ;

Macartney, Kristine K. ;

Akikusa, Jonathan D. ;

Kelly, Julian J. ;

Kirkwood, Carl D. .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (01) :S25-S29

[10] Maternal antibodies to rotavirus: Could they interfere with live rotavirus vaccines in developing countries? [J].

Chan, J. ;

Nirwati, H. ;

Triasih, R. ;

Bogdanovic-Sakran, N. ;

Soenarto, Y. ;

Hakimi, M. ;

Duke, T. ;

Buttery, J. P. ;

Bines, J. E. ;

Bishop, R. F. ;

Kirkwood, C. D. ;

Danchin, M. D. .

VACCINE, 2011, 29 (06) :1242-1247

← 1 2 3 4 5 6 →